- Research works
- 4 ▼ 78% vs 2013–17
- Citations
- 11 2.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 5% world 28%
Not ranked overall: rgb Onkologisches Management is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does rgb Onkologisches Management publish most on?
By volume in 2022–2025: HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies and Cancer Treatment and Pharmacology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HER2/EGFR in Cancer Research Oncology 0 works
- 2 Breast Cancer Treatment Studies Cancer Research 0 works
- 3 Cancer Treatment and Pharmacology Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has rgb Onkologisches Management's research output changed?
Output in 2018–2022 was 78% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sarstedt
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.